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Abstract
Heme, an iron-containing organic ring, is essential for virtually all living organisms by serving
as a prosthetic group in proteins that function in diverse cellular activities ranging from
diatomic gas transport and sensing, to mitochondrial respiration, to detoxification. Cellular
heme levels in microbial pathogens can be a composite of endogenous de novo synthesis
or exogenous uptake of heme or heme synthesis intermediates. Intracellular pathogenic
microbes switch routes for heme supply when heme availability fluctuates in their replicative
environment throughout infection. Here, we show that Toxoplasma gondii, an obligate intra-
cellular human pathogen, encodes a functional heme biosynthesis pathway. A chloroplast-
derived organelle, termed apicoplast, is involved in heme production. Genetic and chemical
manipulation revealed that de novo heme production is essential for T. gondii intracellular
growth and pathogenesis. Surprisingly, the herbicide oxadiazon significantly impaired Toxo-
plasma growth, consistent with phylogenetic analyses that show T. gondii protoporphyrino-
gen oxidase is more closely related to plants than mammals. This inhibition can be
enhanced by 15- to 25-fold with two oxadiazon derivatives, lending therapeutic proof that
Toxoplasma heme biosynthesis is a druggable target. As T. gondii has been used to model
other apicomplexan parasites, our study underscores the utility of targeting heme biosynthe-
sis in other pathogenic apicomplexans, such as Plasmodium spp., Cystoisospora, Eimeria,
Neospora, and Sarcocystis.
Author summary
Toxoplasma gondii infects essentially all warm-blooded animals due to its broad species
and tissue tropism. Almost one-third of the human population carry Toxoplasma infec-
tion, which can cause severe morbidity and mortality in immunocompromised individu-
als. The current antibiotics against Toxoplasma trigger strong side effects in some groups
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of patients and have limited efficacy on congenital toxoplasmosis. Thus, an urgent need
for novel therapeutics exist. Here, we show that Toxoplasma gondii actively produces
heme, a key nutrient for many subcellular activities, via its plant-like heme biosynthesis
pathway for intracellular growth and acute virulence. We found that several herbicidal
heme biosynthesis inhibitors and their derivatives show inhibitory effects against intracel-
lular Toxoplasma growth. Our findings provide evidence that disrupting heme production
in Toxoplasma could be an effective therapeutic strategy to control infection.
Introduction
Human protozoan pathogens share some common nutrient metabolism pathways with their
counterparts in the host but show distinct features. For example, two well-known representa-
tive species within the Apicomplexa Phylum, Toxoplasma gondii and Plasmodium spp., encode
a complete heme biosynthesis pathway in their genomes [1] (Fig 1A and S1 Table). The eight
heme biosynthetic enzymes residing within this pathway are delivered to three subcellular
locations [1–4], including the mitochondrion, cytoplasm, and apicoplast. The apicoplast is a
remnant chloroplast and specifically exists in apicomplexan parasites. Heme typically serves as
a prosthetic group in proteins, such as cytochromes, which play an essential role in mitochon-
drial respiration through the electron transport chain in parasites [5,6]. In addition, Toxo-
plasma encodes orthologs of two other hemoproteins, cytochrome P450 and catalase, in its
genome, suggesting that heme is likely involved in detoxification in Toxoplasma. In contrast,
the malaria parasites lack both genes [1].
The previous studies have successfully expressed active recombinant Toxoplasma porphobi-
linogen synthase (TgPBGS), the second enzyme residing within the parasite’s heme biosynthe-
sis pathway, in E. coli, and solved its three-dimensional structure [7,8]. Moreover,
succinylacetone (SA), an inhibitor targeting TgPBGS activity, was shown to suppress intracel-
lular Toxoplasma growth at a half maximal inhibitory concentration (IC50) of ~ 2 mM, which
sheds light on the therapeutic potential of targeting the heme biosynthetic pathway against
toxoplasmosis [2]. A recent genome-wide CRISPR screen in Toxoplasma calculated the fitness
scores of all eight heme biosynthetic genes to be below -2.7, indicating that the heme biosyn-
thesis pathway is critical in parasite growth [9]. However, it still remains unknown whether
the entire pathway is active for heme production during Toxoplasma infections and the extent
to which Toxoplasma relies on this pathway for its infection.
As an intracellular parasite, Toxoplasma utilizes the host plasma membrane to create its
own membrane-bound compartment for intracellular replication, termed the parasitophorous
vacuole (PV) [10]. The PV membrane (PVM) is permeable to small solutes. Studies have dem-
onstrated that putative nutrient pores exist on the PVM, which allow small substances with
molecular weights less than ~1,300 Da to diffuse into the PV [11]. While heme molecules are
significantly smaller than 1,300 Da, free heme, however, is toxic and therefore unlikely to be
found in a free form. Instead, they are loosely associated with proteins or small ligands that col-
lectively constitute the cellular heme labile pool within mammalian cells [12–14]. Therefore, it
is unlikely that Toxoplasma is able to acquire free heme from the host cells via putative nutrient
pores. Since Toxoplasma can ingest and digest host proteins to support its growth [15], Toxo-
plasma may acquire heme through liberating it from the digestion of the host’s hemoproteins.
Collectively, both the parasite’s de novo heme production and/or heme acquisition from the
host may contribute to parasite replication and infection.
PLOS PATHOGENS Heme metabolism in Toxoplasma gondii
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008499 May 14, 2020 2 / 24
support to defray the publication fee. The funders
had no role in study design, data collection and
analysis, decision to publish, or preparation of the
manuscript.
Competing interests: The authors declare no
competing interests.
Interestingly, the de novo heme biosynthesis pathway exhibits diverse patterns within the
Apicomplexa Phylum. By ortholog search, several other human and animal pathogens besides
Toxoplasma and Plasmodium, including Cyclospora cayetanensis, Cystoisospora suis, Eimeria
Fig 1. Toxoplasma gondii encodes its de novo heme biosynthetic pathway within 3 subcellular locations. a, The working model of the de novo heme
biosynthesis in Toxoplasma parasites. The enzymes catalyzing the de novo heme biosynthesis are distributed within three subcellular locations in the
parasites, whereas they are only localized in the mitochondria and cytoplasm in mammals. b, Determination of the expression of the heme biosynthetic
genes in Toxoplasma during its acute infection and their subcellular locations by endogenous gene tagging with 3xHA or 3xmyc epitopes. A subunit of
Toxoplasma mitochondrial ATPase (TgF1β) and an apicoplast-associated thioredoxin family protein (TgATrx1) were used as the mitochondrial and
apicoplast markers, respectively. TgActin was used as a cytoplasm marker. Bar = 2 μm. ALA, 5-aminolevulinic acid; ALAS, 5-aminolevulinic acid synthase;
Api, apicoplast; Copro III, coproporphyrinogen III; CPOX, Coproporphyrinogen III oxidase; FECH, Ferrochelatase; Gly, glycine; HMB,
hydroxymethylbilan; IVN, intravacuolar network; Mito, mitochondria; PBG, porphobilinogen; PBGD, Porphobilinogen deaminase; PBGS, Porphobilinogen
synthase; PPIX, protoporphyrin IX; PPO, Protoporphyrinogen oxidase; Protogen, protoporphyrinogen IX; PV, parasitophorous vacuole; PVM,
parasitophorous vacuole membrane; SucCoA, Succinyl-CoA; Toxo, Toxoplasma gondii; UROD, Uroporphyrinogen III decarboxylase; Urogen III,
uroporphyrinogen III; UROS, Uroporphyrinogen III Synthase.
https://doi.org/10.1371/journal.ppat.1008499.g001
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tenella, Hammondia hammondi, Neospora caninum, and Sarcocystis neurona, encode a com-
plete or a partial heme biosynthetic pathway (S1 Table). Orthologs missing for some heme bio-
synthetic genes could be due to incomplete coverage of genome sequencing or diverse primary
sequences of these orthologs in apicomplexan parasites. For example, a UROS ortholog is not
identified in the Plasmodium genome by primary sequence alignment with annotated UROS
proteins, but a recent bioinformatic study reported a putative Plasmodium UROS ortholog
with low similarity to annotated UROS [16]. In addition, the enzymatic activity of UROS has
been observed in recombinant Plasmodium PBGD [17], suggesting its unique dual roles in the
heme biosynthesis within Plasmodium. In contrast, Babesia, Theileria, and Cryptosporidium
spp., completely lack the intact pathway [3], suggesting that these apicomplexan parasites have
to scavenge heme from the host. Moreover, malaria parasites switch their requirement for de
novo heme production at different infection stages. The de novo heme biosynthesis is dispens-
able in the blood-stage infection of Plasmodium falciparum [4,18], but is required for its liver-
stage infection [19,20], suggesting that intracellular pathogens could switch their heme
requirements based on heme availability.
Results and discussion
To test whether all 8 genes residing within Toxoplasma’s de novo heme biosynthesis pathway
are expressed in the acute infection stage, we endogenously inserted epitope tags at their C-ter-
mini (S1A Fig). Immunoblotting revealed their active expression during acute toxoplasmosis
(S1C Fig). In addition, fluorescence localization experiments confirmed that Toxoplasma dis-
tributes its heme biosynthesis throughout the mitochondrion, cytoplasm, and apicoplast (Fig
1B, S1B Fig, and S1 Text). Overall, our findings revealed that Toxoplasma maintains de novo
heme biosynthetic components during acute infection.
Given the possibility that Toxoplasma could rely on its de novo heme production or scav-
enge heme or its intermediates from the host to support infection, we deleted 5-aminolevulinic
acid (ALA) synthase (TgALAS, TGGT1_258690), the first enzyme in the pathway, in NanoLuc
luciferase-expressing wildtype (WT::NLuc) Toxoplasma. Disruption of TgALAS will specifi-
cally block the parasite’s de novo heme biosynthesis but maintain the downstream pathway
intact for possible utilization of host-derived heme intermediates (Fig 1A). Generation of
Δalas in standard growth medium was unsuccessful until the medium was supplemented with
300 μM ALA, the product of TgALAS, suggesting that the de novo heme production is essential
for parasite infection. To test this, we evaluated the growth of the resulting Δalas::NLuc mutant
after it was starved in ALA-free medium for 144 h. The pre-starved Δalas::NLuc exhibited
severe growth defects compared to WT::NLuc and ΔalasALAS::NLuc (a TgALAS complemen-
tation strain), and also grew more slowly relative to the non-starved Δalas::NLuc parasites in
the medium lacking ALA (Fig 2A), suggesting that the stored heme reserve within parasites
enhances their intracellular growth when the parasites encounter insufficient heme produc-
tion. In contrast, the pre-starved Δalas::NLuc mutant showed comparable growth compared to
the non-starved Δalas::NLuc when they were grown in the ALA-containing medium (Fig 2A),
indicating that the parasites can quickly respond to extracellular ALA for heme production.
The pre-starved Δalas::NLuc mutant displayed an extremely slow growth rate when it was
grown in the ALA-free medium (Fig 2A), suggesting that the parasites may incorporate a
residual level of heme and/or heme synthesis intermediates from the host. Similarly, we
observed that the Δalas::NLuc parasites showed severe defects in intracellular replication (S3A
Fig) and plaque development (S3B Fig). The addition of 300 μM ALA in the medium enhanced
the replication of TgALAS-deficient parasites regardless of pre-starvation status (S3A Fig). We
also observed that the plaque formation of Δalas::NLuc was partially restored in the medium
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supplemented with 300 μM ALA (S3B Fig and S1 Text). The addition of extracellular ALA
could result in enhanced production and accumulation of toxic porphyrin intermediates in
host cells and infected parasites [6], which may impair intracellular parasite growth. To test
whether ALA can boost parasite growth to a greater extent at ALA concentrations below
300 μM, we compared the growth rates of Δalas::NLuc in media containing 300, 100, 33.3,
11.1, and 3.7 μM ALA. Our data showed that the growth of Δalas::NLuc was enhanced in the
media supplemented with 100 μM and 300 μM ALA, and exhibited a higher increase under
300 μM ALA than 100 μM ALA (S3C Fig). This observation suggests that Toxoplasma parasites
cannot easily access extracellular ALA, probably because ALA needs to cross multiple mem-
branes to reach the parasite’s mitochondrion. To test the role of TgALAS in parasite acute vir-
ulence, we subcutaneously injected the Δalas::NLuc mutant along with WT::NLuc and
ΔalasALAS::NLuc strains into CD-1 mice and did not observe mortality in the mice infected
with the Δalas::NLuc strain, even when its inocula were 103- and 104-fold higher than that
required for WT parasites to establish a lethal infection (Fig 2B). As expected, the infections
derived from WT::NLuc and ΔalasALAS::NLuc strains were lethal at 10–12 days post-infection
(Fig 2B). The parasite infection in the surviving mice was confirmed by seroconversion and
their resistance to subsequent challenge with WT parasites.
To further confirm that the heme biosynthesis pathway is crucial in Toxoplasma, we
attempted to ablate the ferrochelatase (TgFECH, TGGT1_258650), which catalyzes the last step
in heme production. We detected the correct integration of the drug resistance cassette into
the TgFECH locus (S2D Fig) but were unable to generate the straight Δfech knockout, even
upon supplementing the medium with 10 μM heme. Alternatively, we created a TgFECH
knockdown strain using a tetracycline-controlled TET-OFF system. To recognize the targeted
TgFECH, we endogenously tagged its C-terminus with a 3xmyc epitope before replacing its
cognate promoter with a T7S4 promoter, a hybrid of the promoter of Toxoplasma SAG4 (sur-
face antigen 4) gene and the anhydrotetracycline (ATc)-responsive promoter (S4A Fig). The
expression of TgFECH in the resulting knockdown strain, named T7S4-TgFECH-3xmyc, was
below the limit of detection after 144-h treatment of ATc (Fig 2C), and the TgFECH-deficient
mutant showed a drastic replication defect (Fig 2D). Interestingly, if the TgFECH repression
was halted during the replication assay by removing ATc, T7S4-TgFECH-3xmyc parasites sig-
nificantly increased their replication rate compared to those grown in ATc-containing
medium, validating the key role of the de novo heme biosynthesis in parasite intracellular repli-
cation (Fig 2D). Additionally, we individually deleted coproporphyrinogen oxidase (TgCPOX,
TGGT1_223020) and protoporphyrinogen oxidase (TgPPO, TGGT1_272490) within the path-
way. The TgCPOX- and TgPPO-lacking mutants (Δcpox and Δppo, respectively) displayed
approximately 75% and 50% reduction in replication, respectively, compared to WT (Fig 2E
and 2F). A luciferase-based assay also confirmed that both knockout mutants showed severe
growth defects compared to WT parasites (S5A and S5B Fig). Both mutants showed significant
defects in plaque formation as well (S5C and S5D Fig and S1 Text). The deletion of TgCPOX
Fig 2. Toxoplasma parasites principally rely on their de novo heme biosynthesis for intracellular growth and pathogenesis. a, Growth comparison of the
ALA-starved and non-starved Δalas::NLuc parasites in media containing or lacking ALA. The parasites were grown in confluent HFFs and their luciferase
activities were measured every 24 h for up to 96 h. Data represent mean ± SEM of n = 3 biological replicates. b, Acute virulence determination of TgALAS-
deficient parasites in a murine model. Ten mice of equal numbers of males and females were used for each strain. c, Evaluation of repression efficiency of
TgFECH by ATc treatment via immunoblotting. TgFECH was endogenously tagged with a 3xmyc tag at its C-terminus for recognition by immunoblotting.
The lysates were also probed against TgGRA7 as a loading control. d, Replication assessment of the TgFECH knockdown parasites. T7S4-TgFECH and its
parental strains were pre-treated with ATc for the period described in the scheme before replication assay. Data represent mean ± SD of n = 3 biological
replicates. e-f, Replication assay of Δcpox and Δppo parasites. Data represent mean ± SD of n = 3–4 biological replicates. g-h, Acute virulence measurement of
Δcpox and Δppo parasites in a murine model. 5 male and 5 female mice were used for each strain. The statistical significance for each animal study in b, g, and
h was calculated using the Log-rank (Mantel-Cox) test. Statistical significance in the rest of the studies was calculated by two-tailed unpaired Student’s t-test. �,
p<0.05; ��, p<0.01; ���, p<0.001; ����, p<0.0001; n.s., not significant.
https://doi.org/10.1371/journal.ppat.1008499.g002
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or TgPPO also resulted in the complete loss of acute virulence in Toxoplasma (Fig 2G and 2H).
Given that TgPPO is an oxidase, such an oxidation reaction can occur even without enzymatic
catalysis, albeit at lower reaction rates, which could explain why the growth defect shown in
the Δppo mutant is not as severe as that of TgALAS and TgFECH-deficient parasites. These
findings are also consistent with S. cerevisiae, wherein PPO is the only non-essential protein
within its heme biosynthesis pathway [21]. In contrast, CPOX converts coproporphyrinogen
III into protoporphyrinogen IX via decarboxylation. Given that the non-enzymatic decarbox-
ylation rate is extremely slow [22], a spontaneous conversion is unlikely in Δcpox parasites.
Instead, Toxoplasma encodes an oxygen-independent coproporphyrinogen dehydrogenase
(TgCPDH, TGGT1_288640), which may also help bypass the reaction catalyzed by TgCPOX to
sustain partial de novo heme production in the parasites, albeit possibly at a lower level. Collec-
tively, the systematic phenotypic characterization of a series of mutants lacking functional de
novo heme production in Toxoplasma established its crucial importance in parasite growth
and pathogenesis. Although Toxoplasma may acquire heme or its intermediates from the host
via a salvage pathway, it is not sufficient for supporting normal parasite growth and acute
virulence.
To determine that the parasite’s de novo heme biosynthesis pathway is active, we comple-
mented S. cerevisiae heme-deficient mutants lacking ALAS, CPOX, or FECH with the corre-
sponding Toxoplasma ortholog genes. The resulting complementation strains had their heme
auxotrophy phenotypes restored (Fig 3A), whereas the strains complemented with the empty
vector did not grow on heme-free media. Thus, these data establish that TgALAS, TgCPOX,
and TgFECH enzymes are functional. Additionally, total heme abundance in the heme biosyn-
thetic gene knockout and knockdown parasites was quantified using a protoporphyrin IX-
based fluorescence assay [23]. The total heme abundances in Δcpox and Δppo were reduced by
approximately 75% and 50%, respectively (Fig 3B). The heme level in Δalas was nearly 50% rel-
ative to WT parasites when it was grown in medium supplemented with 300 μM ALA, but fell
to approximately 10% when ALA was depleted (Fig 3B). Similarly, the heme abundance in the
TgFECH knockdown strain was decreased to ~15% compared to its parental strain when the
mutant was treated with ATc for 144 h to repress TgFECH expression (Fig 3B). Interestingly,
the parasite replication or growth rates were positively correlated to the total heme abundance
in the parasites (Fig 3C).
We also evaluated whether the de novo heme production within Toxoplasma is responsive
to chemical interference. Succinylacetone (SA), which inhibits de novo heme production by
targeting TgPBGS activity, or ALA, which stimulates heme production, were used for chemical
interrogation of the pathway (Fig 1A). Initially, we determined the half maximal inhibitory
concentration (IC50) of SA for parasite growth inhibition at 665.5 μM using a luciferase-based
growth assay (S7 Fig). Next, we grew T7S4-TgFECH and its parental strain in the ATc-con-
taining media for 144 h, followed by the addition of SA or ALA for an additional 48 h before
heme quantification. The heme levels in parental parasites were increased by ~40% with inclu-
sion of ALA and reduced by ~70% due to SA treatment (Fig 3D), compared to DMSO (vehicle
control)-treated parasites. However, the incubation of ALA and SA in the ATc-treated
T7S4-TgFECH strain did not alter the heme levels in the parasites (Fig 3D). We also found
that the inclusion of ALA in the medium improved parasite replication when the de novo
heme biosynthesis pathway was partially restored in the T7S4-TgFECH strain (Fig 3E). These
findings suggest that the parasite’s de novo heme biosynthesis pathway actively responds to
chemical stimuli for heme production, and the fluctuation in abundance of heme or heme bio-
synthetic intermediates within host cells does not impact heme levels within the parasites.
Taken together, these results indicate that Toxoplasma possesses an active heme biosynthesis
pathway for its heme supply.
PLOS PATHOGENS Heme metabolism in Toxoplasma gondii
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In plants, protoporphyrinogen oxidase (PPO) is involved in heme and chlorophyll produc-
tion [24]. Chlorophyll is an essential pigment for photosynthesis in plants [25]. When PPO
activity is inhibited in plants, the reactant of PPO, protoporphyrinogen IX, leaks into the cyto-
plasm and is spontaneously oxidized to protoporphyrin IX, which can absorb light to produce
highly reactive singlet oxygen that destroys plant cell membranes [26]. Hence, PPO has been
widely recognized as a target for herbicide development [26]. A comparison of primary
sequences of PPOs from mammals, plants, fungi, protozoans, and bacteria indicates that
TgPPO is most closely related to plant orthologs (S8 Fig). Therefore, we evaluated 11 commer-
cial herbicidal PPO inhibitors against WT T. gondii and identified that the IC50 values of 5
compounds ranged from ~130 to 650 μM for the inhibition of parasite growth as determined
by a luciferase-based growth assay (S9 Fig).
Because oxadiazon was the most potent compound identified, and in light of its potential
for additional medicinal chemistry optimization, we next evaluated two derivatives of the scaf-
fold by modifying a structural homolog, oxadiargyl, by means of straightforward cycloaddition
chemistry (Fig 4A). Both derivatives had improved potency, with IC50 values approximately
15-25-fold lower than oxadiazon (Fig 4B). In addition, we found that the Δppo parasites were
less sensitive to these compounds than either WT or ΔppoPPO strains (Fig 4B). To further vali-
date that TgPPO is the in vivo target recognized by oxadiazon and its derivatives, we expressed
TgPPO under the Toxoplasma tubulin promoter in WT::NLuc parental parasites to create a
TgPPO overexpression strain, named WT::NLuc-pTub-TgPPO. By quantitative PCR, the tran-
script level of TgPPO in WT::NLuc-pTub-TgPPO was increased by ~12-fold compared to that
of the parental strain (S10 Fig). Upon overexpression of TgPPO, the IC50 for WT::NLuc-pTub-
TgPPO were increased by 1.5 to 3.2-fold relative to WT::NLuc strain (Fig 4B). These additional
findings suggest that these compounds were targeting TgPPO. Interestingly, we noticed that
the oxadiazon and its derivatives all enhanced the intracellular growth of Δppo parasites when
they were supplemented in the media in the range from 2.1 to 55.5 μM, showing the maximal
growth increase at 55.5 μM for all three PPO inhibitors (Fig 4B). A future follow-up study will
be performed to explore the molecular mechanisms underlying this interesting phenomenon.
The differences in growth were not noted when WT or Δppo parasites were treated with pyri-
methamine, a clinical antibiotic prescribed against acute toxoplasmosis by inhibiting folic acid
synthesis (Fig 4B). The ΔppoPPO strain was less sensitive to pyrimethamine treatment because
a pyrimethamine resistance cassette had been used to generate the TgPPO complementation
plasmid. To test whether these PPO inhibitors reduced heme production in the parasites, the
parental WT::NLuc parasites were treated with 200 μM oxadiazon, or 5 μM Compound 1, or
Fig 3. Toxoplasma harbors an active de novo heme biosynthetic pathway. a, Complementation of Toxoplasma orthologs of heme biosynthetic
genes in the corresponding S. cerevisiae heme-deficient knockouts. EV, empty vector; SD, synthetic defined medium; Ura, uracil. b, Total heme
quantification in heme-deficient parasites. A protoporphyrin IX-based fluorescence assay was used to quantify the total heme. The total heme
levels in transgenic parasite strains were normalized against the corresponding parental strains. Data represent mean ± SEM of n = 3 biological
replicates with 3 technical replicates each. c, The average parasite replication or growth rates showed a positive correlation with the normalized
heme abundances. Given the different genetic backgrounds of parental strains for individual knockouts, the plots were organized in different
groups. The average numbers of parasites per PV for WT, Δcpox, ΔcpoxCPOX, Δppo, and ΔppoPPO were derived from Fig 2E and 2F. The
average numbers of parasites per PV for WT::NLuc, Δalas::NLuc (starved) + ALA, Δalas::NLuc (starved)—ALA, and ΔalasALAS::NLuc were
derived from S3A Fig. The average numbers of parasites per PV for TaTi-TgFECH (ATc-treated) and T7S4-TgFECH (ATc-treated) were
derived from Fig 2D. The normalized growth rates of WT::NLuc, WT::NLuc + ALA, and WT::NLuc + SA at 48 h post-infection were derived
from S7 Fig and S12 Fig. d, Chemical interference in heme production in the parasites requires a functional heme biosynthetic pathway in
Toxoplasma. The TgFECH knockdown parasites, along with its parental strain, were treated with ATc for 144 h before a 48-h stimulation or
repression of heme production by ALA or SA, respectively. The total heme abundances for each treatment per strain were normalized against
the ATc-treated TaTi-TgFECH strain (left panel) or the same strain grown in ATc-containing, but ALA- or SA-lacking, media (right panel).
Data represent mean ± SEM from n = 3 biological replicates. e, Partial restoration of TgFECH expression in ATc-treated T7S4-TgFECH
parasites helped them respond to the growth stimulation by ALA treatment. Data represent mean ± SD of n = 3 biological replicates. Statistical
significance in all of the studies listed in this figure was calculated by two-tailed unpaired Student’s t-test. �, p<0.05; ��, p<0.01; ���, p<0.001;
����, p<0.0001; n.s., not significant.
https://doi.org/10.1371/journal.ppat.1008499.g003
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10 μM Compound 2 for 4 days prior to heme quantification. Our findings revealed that the
heme abundance in WT parasites upon treatment with oxadiazon or its derivatives was
reduced by approximately 15–20% relative to the DMSO-treated parental strain (Fig 4C), fur-
ther supporting the notion that these chemicals target the heme biosynthesis pathway in the
parasites. Notably, none of the compounds were toxic to human foreskin fibroblasts based on
an Alarmar Blue-derived cell viability assay (S11 Fig).
Given the unsuccessful attempts to delete TgFECH in the medium supplemented with
heme, we speculate that Toxoplasma is unable to acquire adequate heme from the host to support
its intracellular growth due to the lack of heme transporter. Supporting this, homology searches
using several identified heme transporters as templates [27,28] failed to identify candidate heme
transporters in the Toxoplasma genome (ToxoDB database). We also used the Δcpox cell line as a
proxy to test whether Toxoplasma can incorporate extracellular heme to support intracellular rep-
lication. There was no significant difference in the quantification of Δcpox replication between
standard growth medium and the medium supplemented with 10 μM heme (Fig 4D). A Δcpox
replication comparison between standard growth medium and the medium containing 300 μM
ALA was included as a positive control (Fig 4D) since Toxoplasma can incorporate extracellular
ALA into its heme biosynthesis pathway as described in a previous publication [6]. A similar
observation was seen in the intracellular growth of Δcpox parasites when comparing growth
within heme-depleted and heme-enriched media (S12 Fig). These observations supported the
concept that the development of a strategy for specific chemical interrogation of the parasite’s
heme biosynthesis shows the therapeutic potential for controlling toxoplasmosis.
Concluding remarks
In conclusion, we revealed that Toxoplasma parasites harbor an active plant-like heme biosyn-
thesis pathway and principally rely on this pathway to produce heme for their intracellular
growth and acute virulence. In addition, the current antibiotics against Toxoplasma trigger
strong side effects in some groups of patients and have limited efficacy on congenital toxoplas-
mosis. Thus, an urgent need for new therapeutics exists. Our findings shed light on the identi-
fication of potential novel therapeutic targets within the parasite’s heme biosynthesis pathway
for the clinical management of Toxoplasma infections.
Materials and methods
Ethics statement
This study was conducted in compliance with the Public Health Service Policy on Humane
Care and Use of Laboratory Animals and Association for the Assessment and Accreditation of
Fig 4. Chemical interrogation of Toxoplasma’s de novo heme production by oxadiazon and its derivatives reduced
the intracellular growth of the parasites. a, Chemical structures of oxadiazon and two derivatives. b, Efficacy
determination of oxadiazon and its derivatives in the inhibition of WT Toxoplasma growth using a luciferase-based
growth assay. The Δppo::NLuc, ΔppoPPO::NLuc, and WT::NLuc-pTub-TgPPO strains were included for evaluating the
target specificity of the inhibitors to TgPPO. Pyrimethamine, an antibiotic targeting folic acid metabolism that is
irrelevant to heme biosynthesis, was also included for assessing the specificity of these PPO inhibitors. Data shown in the
table represent mean ± SEM of n = 3 biological replicates with 3 technical replicates each. The standard errors for
individual IC50s listed in the table were calculated from the IC50s derived from 3 independent biological replicates for
each inhibitor. The IC50 values were obtained by curve fitting using the function of “normalized response” vs.
“[inhibitor]”, under the “dose-response-inhibition” regression program embedded in GraphPad Prism software (8th
version). c, Heme levels were reduced in the parasites upon treatment with oxadiazon and its derivatives. Data shown
here represent mean ± SEM of n = 5 biological replicates. d, Toxoplasma was incapable of taking up extracellular heme to
support its intracellular growth. Data represent mean ± SD of n = 3 biological replicates. Statistical significance for the
assays described in this figure was determined by two-tailed unpaired Student’s t-test. �, p<0.05; ��, p<0.01; ���,
p<0.001; n.s., not significant.
https://doi.org/10.1371/journal.ppat.1008499.g004
PLOS PATHOGENS Heme metabolism in Toxoplasma gondii
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008499 May 14, 2020 11 / 24
Laboratory Animal Care guidelines. Mice that appeared moribund were humanely euthanized
via CO2 overdose, in compliance with the protocol approved by Clemson University’s Institu-
tional Animal Care and Use Committee (Animal Welfare Assurance A3737-01, protocol num-
ber AUP2016-012). This method of euthanasia is consistent with the recommendations of the
Panel on Euthanasia of the American Veterinary Medical Association.
Chemicals and reagents
5-aminolevulinic acid hydrochloride (ALA) was purchased from Ark Pharm (catalog number:
AK-30504). Succinylacetone (SA) was obtained from Sigma-Aldrich (catalog number: D1415-
100MG). Anhydrotetracycline hydrochloride (ATc) was acquired from Cayman Chemical
(catalog number: 10009542). The herbicidal PPO inhibitors were ordered from Chem Service.
Other chemicals used in this work were analytical grade and were purchased from VWR unless
otherwise indicated. All oligonucleotide primers listed in S4 Table for this study were pur-
chased from Eurofins.
Host cells and parasite culture
Human foreskin fibroblasts (HFFs) were obtained from the American Type Culture Collection
(ATCC, catalog number: SCRC-1041). Tissue cultures were maintained at 37˚C with 5% CO2 in
D10 medium (Dulbecco’s Modified Eagle Medium, 4.5 g/L glucose, VWR) supplemented with
10% Cosmic Calf serum (HycloneTM, GE Healthcare Life Sciences SH30087.03), 10 mM HEPES,
additional 2 mM L-glutamine, and 10 mM Pen/Strep as instructed by the vendor’s manual.
The HFF cells were tested for mycoplasma contamination every month. Toxoplasma strain
RHΔku80Δhxg and TaTiΔku80Δhxg were obtained from the Carruthers Lab (Univ of Michigan)
and the Striepen Lab (Univ of Pennsylvania), respectively, who originally created these Toxo-
plasma parental strains [29,30]. All Toxoplasma strains were maintained in vitro by serial passage
on HFFs. The Δalas::NLuc strain was kept in the D10 medium supplemented with 300 μM ALA.
Generation of transgenic T. gondii strains (S2 Table)
(1) Endogenously epitope-tagging the heme biosynthetic genes. The RHΔku80Δhxg
strain was used as the parental strain for endogenous gene tagging. The TgALAS, TgALAD,
TgCPOX, TgPPO, and TgFECH were endogenously tagged with a 3xHA epitope at their C-ter-
mini by CRISPR-Cas9-mediated double crossover recombination as described previously [31].
The TgPBGD, TgUROS, and TgUROD were endogenously tagged with a 3xmyc tag C-terminally
using similar methods as mentioned above. Briefly, the guide RNA selected to target the 3’-end
of the coding sequence for individual genes was incorporated into a guide RNA expression con-
struct as described previously [32]. This construct also encodes Cas9 protein that assists the
guide RNA in generating a double-stranded break at the end of genes of interest. Fifty base
pairs of homologous regions upstream and downstream stop codon were engineered into for-
ward and reverse primers, respectively. By PCR, they were flanked at the 5’- and 3’-ends of the
epitope tag and a drug resistance cassette, respectively, to create a repair template. The guide
RNA/Cas9 expression plasmids and the repair template were co-introduced into the parental
strain by electroporation. Through double-crossover homologous recombination, the epitope
tag and drug resistance cassette were incorporated after the last codon of individual genes (S1A
Fig). The resulting strains expressing epitope-tagged genes were drug selected and cloned out.
The primers used for the epitope tagging of individual genes are listed in the S4 Table.
(2) Genetic ablation of the heme biosynthetic genes. A similar CRISPR-Cas9-based
gene editing strategy was conducted for the deletion of TgCPOX and TgPPO in the
RHΔku80Δhxg strain, and the ablation of TgALAS in the RHΔku80::NLuc strain generated in
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our previous study [31]. Similarly, the 50-bp homologous upstream and downstream DNA
sequences of the start and stop codons of the corresponding gene, respectively, were incorpo-
rated into primers for amplification of the drug resistance cassette by PCR. In the final PCR
product, the homologous regions located at both ends of the target gene facilitated the replace-
ment of the gene of interest with a drug resistance cassette by double crossover recombination.
For individual genes, the PCR product was mixed with the corresponding guide RNA used for
the endogenous gene tagging and electroporated into RHΔku80Δhxg or RHΔku80Δhxg::NLuc
strains for knockout mutant generation. The correct clones were drug selected and cloned out
as described previously [31]. PCR was used to verify the integration of the drug resistance cas-
sette in the correct locus (S2A and S2B Fig). The primers used for the deletion of individual
genes and the verification of the knockout mutants are listed in the S4 Table and S2 Text.
Please refer to S1 Text for more details.
(3) Complementation of the heme-deficient Toxoplasma knockouts. To restore the
gene expression in the corresponding heme-deficient knockouts, we PCR-amplified the coding
sequences of the individual heme biosynthetic genes from the Toxoplasma cDNA library and
the corresponding 1kb 5’- and 3’-UTR (untranslated regions) from the Toxoplasma genomic
DNA. All three PCR products for individual genes were assembled into a plasmid vector carry-
ing the pyrimethamine resistance cassette to create the corresponding complementation con-
structs. For both TgPPO and TgALAS complementation constructs, a 1kb DNA fragment
localized to ~ 6kb upstream TgKU80 gene was included in the complementation construct to
facilitate a single insertion of the complemented gene into the genome of the knockout strain
to keep its expression similar to its endogenous expression level. Approximately twenty micro-
grams of complementation plasmids were used for transfection. After stabilization by drug
selection, the complemented parasites were cloned out. PCR was used to verify the integration
of the exogenous genes introduced into the parasite’s genome. Additionally, the total RNA
from the knockouts, their parental strains, and the corresponding complementation strains
were purified and tested by RT-PCR to confirm the loss of their messenger RNAs in the
knockouts and the restored expression in the complementation strains (S2C Fig). The primers
used for the complementation of individual genes in the corresponding Toxoplasma knockout
mutants and the verification of their integration are listed in the S4 Table.
(4) Generation of the ferrochelatase (TgFECH) knockdown strain using the tetracy-
cline-controlled TET-OFF system. The TaTiΔku80Δhxg strain carries the required genetic
elements to suppress gene expression in response to the treatment of anhydrotetracycline
(ATc) [30] and therefore is being used as a parental strain to knock down the TgFECH gene.
To help recognize and evaluate the expression repression of TgFECH, we first endogenously
tagged it with a 3xmyc epitope C-terminally, as described above, to create a TaTiΔku80::
TgFECH-3xmyc strain. A 1kb region upstream the start codon of TgFECH was recognized as
the promoter region and targeted for replacement with a tetracycline-responsive T7S4 pro-
moter. To achieve this, the 50-bp regions upstream and downstream the TgFECH start codon
were incorporated at the 5’- and 3’-ends of the pyrimethamine resistance cassette and a tetra-
cycline-responsive T7S4 promoter by PCR using a similar strategy as mentioned above. A sin-
gle clone of TaTiΔku80::TgFECH-3xmyc was transfected with the T7S4 promoter-encoding
PCR product, along with a guide RNA expression construct recognizing the 5’-end of TgFECH
gene, to create a T7S4-TgFECH-3xmyc strain. Please refer to S4A Fig for the schematic
description of the detailed steps. The epitope tag integration and the promoter replacement
were confirmed by PCR (S4B Fig). The primers used for the generation of the TgFECH knock-
down strain and its verification are listed in the S4 Table.
(5) Generation of nanoLuc luciferase (NLuc)-expressing parasite strains. The NLuc
expression plasmids were introduced into individual Δcpox and Δppo parasite strains and the
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corresponding ΔcpoxCPOX and ΔppoPPO complementation strains. The resulting NLuc-
expressing strains were drug-selected and cloned out. Individual clones for each strain were
screened by their luciferase activities to help select clones expressing similar levels of NLuc
activity. These clones were maintained for downstream assays including intracellular growth
and IC50 determination for PPO inhibitors.
(6) Generation of a transgenic strain overexpressing TgPPO. The coding sequence of
TgPPO was PCR-amplified and placed downstream a Toxoplasma tubulin promoter for its over-
expression in Toxoplasma parasites. The resulting plasmid also encodes a pyrimethamine resis-
tance cassette for drug-selection of the parasites that overexpress TgPPO. The WT::NLuc parasites
were transfected with the TgPPO overexpression plasmid using the standard electroporation pro-
tocol documented in our previous publication [31]. The transfectants were further stabilized by
drug selection and cloned out. PCR was used to screen the clones carrying the exogenously intro-
duced plasmid. Quantitative PCR was also performed on the screened clones to evaluate the level
of TgPPO transcript for confirmation of its overexpression before drug efficacy testing.
Quantitative PCR (qPCR) assay
Toxoplasma parasites were grown in HFF cells for 2 days before total RNA purification. Filter-
purified parasites were subjected to a trizol-based method for total RNA extraction by using
the Direct-zol RNA MiniPrep Plus kit (Zymo). Approximately 300 ng of total RNA was used
to detect and/or quantify the steady levels of transcripts for individual genes by using the Luna
Universal One-Step RT-PCR kit (NEB). The data acquisition for the qPCR assay was per-
formed using the BioRad CFX96 Touch Real-Time PCR detection system. The double delta
cycle threshold (ΔΔCT) analysis was used to calculate the relative abundances of the transcripts
for individual genes in transgenic parasite strains compared to that in WT parasites using the
Bio-Rad CFX Maestro software. TgActin was used for normalization as the housekeeping gene.
SDS-PAGE and immunoblotting
Toxoplasma parasites were grown and maintained in HFFs for a routine 2-day pass. Filter-
purified parasites were resuspended in 1x SDS-PAGE sample buffer (40 mM Tris, pH 6.8, 1%
SDS, 5% glycerol, 0.0003% bromophenol blue, 50 mM DTT) and boiled for 10 min prior to
resolving by SDS-PAGE. Separated polypeptides were transferred to PVDF membranes via
semi-dry protein transfer. For chemiluminescence-based detection, blots were blocked with
5% non-fat milk, incubated with primary antibody diluted in 1% non-fat milk in PBS, followed
by probing with goat anti-mouse or anti-rabbit IgG antibodies conjugated with horseradish
peroxidase as the secondary antibody diluted in 1% non-fat milk in PBS. Immunoblots were
developed with SuperSignal WestPico chemiluminescent substrate (Thermo Fisher). For fluo-
rescence-based detection, blots were blocked with 1.25% fish gelatin in 50 mM Tris, pH 7.4,
0.15 M NaCl, incubated with primary antibody diluted in wash buffer (0.1% Tween-20 in
PBS), followed by probing with goat anti-mouse or anti-rabbit IgG antibodies conjugated with
680RD or 800CW dyes as the secondary antibody (LI-COR). The chemiluminescence and
fluorescence signals were captured using the Azure C600 Imaging System.
Immunofluorescence microscopy
Freshly lysed parasites were used to infect confluent HFF cells pre-seeded in an 8-well chamber
slide for 1 h (pulse-invaded parasites) or 28–40 h (replicated parasites). Immunofluorescence
was performed as described previously [31]. Images were viewed and digitally captured using a
Leica CCD camera equipped with a Leica DMi8 inverted epifluorescence microscope and pro-
cessed with Leica LAS X software.
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PPIX-based total heme quantification
The parasites were grown in HFFs for 2 days in regular D10 medium or the medium supple-
mented with chemicals indicated in the text before harvest. Freshly lysed parasites were
syringed, filter-purified, and washed in ice-cold PBS buffer. The parasites were finally resus-
pended in 400 μl of ice-cold PBS buffer, and sonicated on ice using a Branson analog sonifier
with a mini horn at the output intensity setting of 3 and duty% of 20%, at a 10-sec interval, for
4 times. A thirty-second rest was set between each sonication to avoid overheating. One hun-
dred microliters of samples were mixed with 900 μl of 2 M oxalic acid in solid black Eppendorf
tubes and boiled for 30 min. Similarly, each sample was duplicated in the same way without
boiling, serving as a background reading. The heme solutions at 0, 5, 14.7, 44.3, 133, 400, and
1200 nM were included in the assay to produce a standard curve. The fluorescence was
recorded at 400 nm excitation wavelength and 608 nm emission wavelength using the BioTek
H1 Hybrid plate reader. The fluorescence of non-boiled samples will be subtracted from that
of boiled samples. The final fluorescence was normalized against the amount of parasites for
comparison. The normalized heme abundance in WT parasites was set at 100% to calculate
the relative heme abundance in other strains.
Plaque assay of T. gondii
Freshly egressed parasites were filter-purified and resuspended in D10 medium. Two hundred
parasites were inoculated into a 6-well plate seeded with confluent HFFs. The plate was incu-
bated at 37˚C with 5% CO2 for 7 days without disturbance. The developed plaques were
stained with 0.002% crystal violet in 70% ethanol for 5 min and washed with water to enhance
visualization of developed plaques. The plaques were scanned to capture the images of entire
wells or observed under 25x magnification using a Leica DMi8 microscope. At least 50 individ-
ual plaques were photographed for measurement of their sizes. The plaque size was plotted for
comparison.
Replication assay of T. gondii
For the parasite replication assay, freshly lysed parasites were filter-purified and inoculated
into individual wells of an 8-well chamber slide pre-seeded with HFF cells at approximately 1 x
105 cells per well and incubated at 37˚C with 5% CO2. Non-invaded parasites were washed off
at 4 h post-infection. Invaded parasites were allowed to infect host cells for an additional 24
and 36 h before fixation. The infected host cells were stained with monoclonal anti-TgGRA7
(1:2,000) antibody and DAPI to help distinguish individual parasitophorous vacuoles (PVs)
and parasite nuclei, respectively. Slides were subjected to standard immunofluorescence
microscopy for imaging. One hundred PVs were enumerated for each strain and plotted as
average parasites per PV for comparison.
Bioluminescence-based growth assay
Individual strains were purified, resuspended in D10 medium, and inoculated into 96-well
plate pre-seeded with confluent HFFs. Parasites were allowed to invade host cells for 4 h at
37˚C with 5% CO2 before washing away non-invaded parasites, and the bioluminescence of
invaded parasites at 4 h post-infection was measured for normalization. Invaded parasites
were incubated at 37˚C with 5% CO2 for an additional 96 h, and their bioluminescence was
measured every 24 h and normalized against the signal derived at 4 h for the calculation of the
fold change of bioluminescence, which reflects parasite intracellular growth rate.
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Mouse studies
Six- to eight-week-old, outbred CD-1 mice were infected with WT or transgenic parasite
strains diluted in PBS, with inocula indicated in the text, by subcutaneous injection. The
infected mice were monitored daily for developing symptoms over 30 days. CO2 overdose was
used to euthanize mice. The seroconversion of the surviving mice was tested by enzyme-linked
immunosorbent assay (ELISA). The surviving mice were allowed to rest for 10 days, prior to a
subcutaneous challenge injection with 1,000 WT parasites, and were kept for daily monitoring
of survival for an additional 30 days. The mice survival curve was plotted for statistical signifi-
cance calculation by using the Log-rank (Mantel-Cox) test.
Yeast complementation assay
To test the functionality of the Toxoplasma orthologs of the heme biosynthetic proteins, we
complemented these orthologs in the corresponding yeast knockouts (S3 Table). First, we
PCR-amplified the G418 resistance cassette from the plasmid pFA6a-6xGLY-Myc-kanMX6
(Addgene, plasmid #:20769), flanked by 50-bp upstream and downstream regions of the start
and stop codons of the corresponding heme biosynthetic gene, respectively. Approximately
5 μg of PCR products were transformed into the haploid yeast strain BY4741 (GE Healthcare
Dharmacon Inc., catalog number: YSC 1048) to remove the coding sequences of heme biosyn-
thetic genes by homologous recombination using standard yeast transformation procedures
(S6A Fig). The transformants were selected on YPD plates containing 200 μg/ml of G418 and
15 μg/ml hemin. After two to three days of incubation, correct yeast knockouts were identified
by PCR (S6B Fig). Next, we amplified the coding sequences of the corresponding Toxoplasma
orthologs of individual heme biosynthetic genes from the Toxoplasma cDNA library by PCR
and drove its expression under the promoter of the yeast TEF1 gene in the pXP318 yeast
expression construct to create a complementation construct. The yeast complementation con-
struct was chemically introduced into the corresponding yeast knockout. The pXP318 encodes
a uracil biosynthesis gene, while the WT yeast strain shows a uracil auxotrophy phenotype.
Therefore, the successful transformants receiving pXP318 or pXP318-derived plasmids did
not require the addition of uracil in the growth medium. The yeast knockouts complemented
with the corresponding Toxoplasma orthologs were also patched onto plates lacking exoge-
nously added heme to evaluate a heme autotrophy phenotype. The primers used for the yeast
knockout generation and complementation of individual Toxoplasma orthologs are listed in
the S4 Table and S2 Text.
Synthesis of oxadiazon derivatives
All reagents were purchased from commercial sources and used without purification. 1H and
13C NMR spectra were collected on Bruker 300 MHz NMR spectrometers using CDCl3 as the
solvent. Chemical shifts are reported in parts per million (ppm). Spectra are referenced to
residual solvent peaks. Infrared spectroscopy data were collected using an IR Affinity-1S
instrument (with MIRacle 10 single reflection ATR accessory). Flash silica gel (40–63 μm) was
used for column chromatography. The compounds were characterized by 1H and 13C NMR,
ATR-FTIR, and HRMS. HRMS data were collected using an instrument equipped with elec-
trospray ionization in positive mode (ESI+) and a Time Of Flight (TOF) detector (S13 and S14
Figs).
General Procedure for Oxadiargyl-triazole analogs [33]: Oxadiargyl (50 mg, 0.145 mmol,
1.0 equiv) was dissolved in DCM/H2O, 1:1 (0.5 mL) in a 20 mL round-bottomed flask
equipped with a stir bar. The appropriate azide (0.175 mmol, 1.2 equiv) was added, followed
by anhydrous CuSO4 (1 mg, 0.007 mmol, 0.05 equiv) and sodium ascorbate (4 mg, 0.02 mmol,
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0.15 equiv). The resulting solution was then stirred vigorously at room temperature for 4 h.
The reaction was diluted with DCM (5 mL) and water (5 mL). The organic layer was washed
with saturated aq. brine, dried over anhydrous sodium sulfate, and concentrated by rotary
evaporation to provide the crude product as a brown oil. The isolate was purified by silica gel
flash column chromatography under the following gradient: hexanes (20 mL), ethyl acetate/
hexanes (95:5; 20 mL), ethyl acetate/hexanes (90:10; 50 mL), ethyl acetate/hexanes (80:20; 50
mL), ethyl acetate/hexanes (70:30; 50 mL), ethyl acetate/hexanes (50:50; 50 mL) to afford an
opaque oil (62–87% isolated yield).
3-(5-((1-benzyl-1H-1,2,3-triazol-4-yl)methoxy)-2,4-dichlorophenyl)-5-(tert-butyl)-
1,3,4-oxadiazol-2(3H)-one (Compound 1). Compound 1 was obtained in 62% yield using
benzyl azide [34] (23 mg, 0.18 mmol, 1.2 equiv) as the azide reagent.
Opaque oil; Yield: 62% (69 mg); Rf 0.54 (1:1 ethyl acetate/hexanes, UV); IR: (film) = 2970,
2924, 2856, 2094, 1782, 1489, 1246, 752, 717 cm-1; 1H NMR: (300 MHz, CDCl3) δ 1.39 (s, 9H),
δ 5.29 (s, 2H), δ 5.55 (s, 2H), δ 7.24 (s, 1H), δ 7.30 (m, 2H), δ = 7.38 (m, 2H), δ 7.52 (s, 1H), δ
7.61 (s, 1H); 13C{1H} NMR: (75 MHz, CDCl3) δ = 27.0, 32.9, 54.3, 63.7, 113.8, 123.0, 123.9,
125.2, 128.1, 128.9, 129.2, 131.4, 134.3, 142.6, 152.0, 152.9, 163.6; HRMS (ESI-TOF): Calcd. for
C22H22Cl2N5O3, [M+H]
+ 474.1100 found m/z 474.1099.
5-(tert-butyl)-3-(2,4-dichloro-5-((1-octyl-1H-1,2,3-triazol-4-yl)methoxy)phenyl)-
1,3,4-oxadiazol-2(3H)-one (Compound 2). Compound 2 was obtained in 87% yield using
octyl azide [35] (24 mg, 0.18 mmol, 1.2 equiv) as the azide reagent.
Opaque oil; Yield 87% (72 mg); Rf 0.50 (1:1 ethyl acetate/hexanes, UV); IR: (film) = 2951,
2924, 2854, 1786, 1479, 1246, 1126, 1041, 733 cm-1; 1H NMR: (300 MHz, CDCl3) δ = 0.87 (t,
3H, J = 7 Hz), 1.26 (m, 12H), 1.38 (s, 9H), 1.92 (p, 2H, J = 7 Hz), 4.36 (t, 2H, J = 7 Hz), 7.26 (s,
1H), 7.52 (s, 1H), 7.68 (s, 1H); 13C{1H} NMR: (75 MHz, CDCl3) δ = 27.0, 32.9, 54.3, 63.7,
113.8, 122.9, 123.9, 125.1, 131.4, 142.6, 152.0, 152.9, 163.6; HRMS (ESI+-TOF): Calcd for
C23H31Cl2N5O3, [M+H]
+ 496.1882 Found m/z 496.1878.
In vitro measurement of IC50s for chemical inhibitors
General procedures: Individual parasite strains expressing NanoLuc luciferase were used to
infect confluent HFFs pre-seeded into a 96-well solid white plate with inocula of 1,000 tachy-
zoites per well for WT::NLuc and ΔppoPPO::NLuc strains, and 3,000 tachyzoites per well for
the Δppo::NLuc strain. A higher inoculum of Δppo::NLuc was adjusted in the assay to help
accurately quantify fold change of luciferase activity due to its slow growth. Purified parasites
were resuspended in phenol red-free D10 medium, and 150 μl of parasite resuspension for
individual strains were inoculated in each well. Parasites were initially incubated at 37˚C with
5% CO2 for 4 h to facilitate host invasion. Next, the media were gently aspirated and replaced
with the phenol red-free D10 media containing individual chemical inhibitors at the serially
diluted concentrations listed below. Control medium without an inhibitor was included for
luciferase activity normalization. After a 2- to 4-day incubation with chemical inhibitors, the
media were gently aspirated to avoid disturbance of the infected HFF monolayer, replaced
with 12.5 μM Coelenterazine h in lysis buffer (100 mM 4-Morpholineethanesulfonic acid
(MES) pH 6.0, 1 mM trans-1,2-Diaminocyclohexane-N,N,N0,N0-tetraacetic acid (CDTA),
0.5% (v/v) Tergitol, 0.05% (v/v) Mazu DF 204, 150 mM KCl, 1 mM DTT, and 35 mM thiourea)
[36], and incubated at room temperature for 10 min to fully lyse cells prior to luciferase activity
quantification. The signals from wells of each individual concentration of inhibitors were
recorded using a BioTek plate reader and normalized against the luciferase activities derived
from the infected cells incubated in plain medium. The normalized luciferase activities were
plotted against the concentrations of inhibitors to calculate the IC50 values for individual
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inhibitors using the built-in “Dose-response-inhibition” program in GraphPad Prism software
(8th version).
Measurement of IC50s for the PPO inhibitors. The serial concentrations of PPO inhibi-
tors were 500.0, 125.0, 31.3, 7.81, 1.95, 0.488, 0.122, 3.05x10-2, and 7.63x10-3 μM. The efficacies
of these inhibitors were only tested on WT::NLuc parasites after 4 days of growth.
Measurement of IC50s for oxadiazon and its derivatives. The serial concentrations of
oxadiazon and its derivatives were 500.0, 166.7, 55.6, 18.5, 6.17, 2.06, 6.8x10-1, 2.3x10-1, 7.6x10-
2, 2.5x10-2, and 8.5x10-3 μM. The efficacies of these inhibitors were tested on WT::NLuc, Δppo::
NLuc, and ΔppoPPO::NLuc parasites after 4 days of growth.
Measurement of IC50 for pyrimethamine. The serial concentrations of pyrimethamine
included in the media were 100.0, 33.3. 11.1, 3.70, 1.23, 0.41, 0.14. 0.045, 0.015, 5.1x10-3, and
1.7x10-3 μM. The efficacy of pyrimethamine was tested on WT::NLuc, Δppo::NLuc, and
ΔppoPPO::NLuc parasites after 4 days of growth.
Measurement of IC50 for succinylacetone. The serial concentrations of succinylacetone
included in the media were 6,666.6, 2,222.2, 740.7, 246.9, 82.3, 27.4, 9.14, 3.05, and 1.02 μM.
The IC50 value of succinylacetone was determined using its inhibition on 2-day growth of
WT::NLuc parasites.
Resazurin-based cell viability assay
The HFFs were seeded in 96-well plates and grown in regular D10 medium. After the host cells
became confluent, they were incubated in media containing the tested PPO inhibitors at the seri-
ally diluted concentrations of 500.0, 166.7, 55.6, 18.5, 6.17, 2.06, 6.8x10-1, 2.3x10-1, 7.6x10-2,
2.5x10-2, and 8.5x10-3 μM, or the media containing Triton X-100 at 1070.0, 356.7, 118.9, 39.6,
13.2, 4.40, 1.47, 0.49, 0.16, 0.054, and 0.018 μg/ml for 4 days. The host cells grown in regular D10
medium were included as the control for normalization. The resazurin was diluted at 0.004% in
regular D10 medium and incubated with host cells at 37˚C with 5% CO2 for 4 h before absor-
bance measurement at 570 and 600 nm using a BioTek H1 Hybrid plate reader. A resazurin-con-
taining medium control that was not incubated with host cells was included to calculate the
absorbance ratio of oxidized resazurin at 570 nm vs. 600 nm, termed OD(blank)570/600. The nor-
malized cell viability was calculated using the following equation: [OD(inhibitor)570—OD(inhibi-
tor)600 x OD(blank)570/600]/ [OD(medium)570—OD(medium)600 x OD(blank)570/600]
�100%.
Phylogenetic tree construction
Polypeptide sequences of 17 PPO orthologs from animals, plants, bacteria, protozoa, and fungi
were retrieved from the Uniprot database (www.uniprot.org). The sequences were aligned using
the CLUSTAL MUSCLE (MUltiple Sequence Comparison by Log-Expectation) alignment tools
[37,38]. The resulting sequence alignment was used to construct a phylogenetic tree by using the
Neighbor-Joining tree analysis [39] built into the Geneious software. Bootstrap values based on
10,000 replicates are shown. The accession IDs used for MUSCLE alignment were listed in S8 Fig.
Statistical significance calculation
The statistical significance calculation in this study was performed using GraphPad Prism soft-
ware (8th version). The methods for individual assays were indicated in the figure captions.
Supporting information
S1 Fig. Endogenous epitope tagging of the Toxoplasma heme biosynthetic genes. a, Sche-
matic illustration of the endogenous gene epitope tagging in Toxoplasma. In brief, a 3xHA or
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3xmyc tag was fused at the C-termini of the genes of interest using a CRISPR-Cas9-based clon-
ing strategy. b, TgUROD was localized to the apicoplast, instead of the cytoplasm. TgActin
was used as a cytoplasm marker. Bar = 2 μm. c, Immunoblotting analysis was used to confirm
the expression of the epitope-tagged genes. The bands labeled with asterisks were derived from
non-specific binding to antibodies. For TgALAS-3xHA, two protein fragments denoted by the
filled arrowheads, migrating at ~80 kDa and ~40 kDa, represent the full-length and truncated
TgALAS proteins, respectively. The TgPBGS gene only can be endogenously epitope-tagged in
a transient manner. The protein lysate was purified from parasites that lysed immediately after
transfection with the guide RNA expression construct and a TgPBGS-3xHA tagging DNA
fragment. The guide RNA expression construct also expressed the 3xHA-tagged Cas9 proteins.
Based on the predicted molecular weight, the band denoted by an unfilled arrowhead was
derived from 3xHA-tagged Cas9. GOI, gene of interest; DRC, drug resistance cassette.
(TIF)
S2 Fig. Genetic deletion of the Toxoplasma heme biosynthetic genes. a, Schematic illustra-
tion of a general CRISPR-Cas9-based strategy for gene deletion in Toxoplasma. b, PCR confir-
mation of gene ablation. The genomic locations of the primers used in PCR amplification were
indicated in the scheme. c, The loss of messenger RNA of the genes of interest was confirmed
by reverse-transcription PCR (RT-PCR). d, The correct integration of the drug resistance cas-
sette into the TgFECH locus during gene deletion was detected by PCR. However, the knock-
out parasites cannot be cloned probably due to its non-viability. GOI, gene of interest; DRC,
drug resistance cassette.
(TIF)
S3 Fig. TgALAS-deletion mutant showed defective replication and plaque formation and
required extracellular ALA for intracellular growth. a, Replication comparison of the ALA-
starved and non-starved Δalas::NLuc parasites in the media containing or lacking ALA. The
average numbers of parasites per PV used in the figure were listed in a separate table. Data rep-
resent mean ± SD of n = 3 biological replicates. b, The Δalas::NLuc mutant formed smaller pla-
ques relative to WT::NLuc and ΔalasALAS::NLuc strains. The defect can be partially restored
upon the addition of 300 μM ALA in the growth medium. Fifty plaques from 3 independent
assays were measured using phase contrast light microscopy. Bar = 500 μm. Data represent
mean ± SD. c, Concentration titration of ALA in restoring intracellular growth defects of the
Δalas::NLuc mutant. Parasite growth enhancement was observed when the medium was sup-
plemented with 100 μM and 300 μM ALA and was restored to a greater extent with 300 μM
ALA. Statistical significance was calculated by two-tailed unpaired Student’s t-test. �, p<0.05;
��, p<0.01; ���, p<0.001; ����, p<0.0001; n.s., not significant.
(TIF)
S4 Fig. TgFECH expression was regulated by a tetracycline-inducible TET-OFF system. a,
Graphic description of gene epitope tagging and promoter swapping for the TgFECH gene. b,
PCR verification of the integration of the 3xmyc tag and TET-OFF promoter into the TgFECH
locus. Primers used in this study were indicated in the scheme.
(TIF)
S5 Fig. TgCPOX- and TgPPO-deficient mutants exhibited defects in intracellular growth
and plaque development. a-b, The heme-deficient parasites were grown in confluent HFFs
and their luciferase activities were measured every 24 h for up to 96 h. The luciferase activities at
4 h post-infection were also determined for normalization. Error bars represent SEM. The assays
were repeated in triplicate. c-d, The Δcpox and Δppo mutants displayed smaller plaques than
WT and the corresponding complementation strains. The plaques were allowed to develop in
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confluent HFFs for 7 days, without disturbance, before staining with crystal violet. Fifty plaques
from 3 independent assays were measured using phase contrast light microscopy to compare
their sizes. Bar = 500 μm. Data represent mean ± SD. Statistical significance was determined by
two-tailed unpaired Student’s t-test. �, p<0.05; ����, p<0.0001; n.s., not significant.
(TIF)
S6 Fig. Generation of heme-deficient yeast strains. a, Schematic illustration of the gene dele-
tion strategy. b, PCR was used to verify the loss of the heme biosynthetic genes in yeast. Prim-
ers used in the study were labeled in the scheme. GOI, gene of interest; DRC, drug resistance
cassette.
(TIF)
S7 Fig. Determination of the IC50 values for succinylacetone (SA) in parasite growth. A
luciferase-based assay was used for the determination. The IC50 values presented in the figure
represent means ± SEM of n = 5 biological replicates.
(TIF)
S8 Fig. Phylogenetic analysis of protoporphyrinogen oxidase (PPO). Neighbor-Joining con-
sensus tree analysis of the relationships of 17 PPO family proteins derived from animals,
plants, protozoa, fungi, and bacteria. Bootstrap values based on 10,000 replicates are shown.
Accession numbers of protoporphyrinogen oxidase from individual species were listed in the
parentheses. A human NADPH oxidase was also included as an outgroup for phylogeny con-
struction. The closely related PPO orthologs were shaded in individual colors. Consensus
bootstrap support (%) was labeled in the figure.
(TIF)
S9 Fig. Screening of 11 commercially available PPO-targeting herbicides in the growth
inhibition of Toxoplasma parasites. The five most potent inhibitors were identified with their
IC50 values in the range of ~130–650 μM. Six inhibitors did not show significant inhibitions
on parasite growth. The IC50 values for the top 5 known inhibitors were reported as
means ± SEM of n = 3 biological replicates with 3 technical replicates each.
(TIF)
S10 Fig. Quantitative PCR validation of TgPPO overexpression in the WT::NLuc-pTub-
TgPPO strain. The qPCR assay was repeated in three biological replicates with three technical
replicates each. Data shown in the figure were represented as mean ± SEM. TgActin was used
as a normalization control. Statistical significance was calculated by two-tailed unpaired Stu-
dent’s t-test. ���, p<0.001.
(TIF)
S11 Fig. Evaluation of the toxicity of the synthesized oxadiazon derivatives in HFFs. An
AlarmarBlue-based cell viability assay was used to evaluate the toxicity of oxadiazon and its
derivatives. Triton X-100 was used as a positive control in the assay. Data represent
means ± SEM of n = 3 biological replicates with 3 technical replicates each.
(TIF)
S12 Fig. Extracellular heme did not rescue the intracellular growth of the Δcpox parasites.
A luciferase-based growth assay was used to measure the growth of the Δcpox parasites in
media containing or lacking 10 μM heme. The ALA-containing medium was used as a positive
control. Data shown here represent means ± SEM of n = 3 biological replicates with 3 technical
replicates each. Statistical significance was determined by two-tailed unpaired Student’s t-test.
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�, p<0.05; n.s., not significant.
(TIF)
S13 Fig. Chemical structure validation of compound 1 by 1H and 13C NMR spectra.
(TIF)
S14 Fig. Chemical structure validation of compound 2 by 1H and 13C NMR spectra.
(TIF)
S1 Text. Description of the localization of TgUROD in the parasites, the generation of
heme-deficient Toxoplasma strains, and plaque assay.
(DOCX)
S2 Text. Primers used in S2 Fig and S6 Fig.
(DOCX)
S1 Table. Ortholog search of heme biosynthetic genes in apicomplexan parasites using the
Basic Local Alignment Search Tool (BLAST). Gene IDs listed in the table were identified by
searching for orthologs of heme biosynthetic proteins in www.eupathdb.org.
(XLSX)
S2 Table. Toxoplasma strains used in this study.
(XLSX)
S3 Table. Yeast strains used in this study.
(XLSX)
S4 Table. Primers used in this study.
(XLSX)
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